: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

The Angels Initiative

Stroke prevention

Bladder Cancer, January 2019
Free Subscription

Abstracts
Retrieve all available abstracts of the following 396 articles:
HTML format

Single Articles

NESI G, Galli IC, Amorosi A, Santi R, et al
Environment and urinary bladder cancer. A historical perspective.
Pol J Pathol. 2019;70:21-25.
Abstract Related articles

ZHANG Z, Xu H, Ji J, Shi X, et al
Heterogeneity of PTEN and PPAR-gamma in cancer and their prognostic application to bladder cancer.
Exp Ther Med. 2019;18:3177-3183.
Abstract Related articles

SIM WJ, Iyengar PV, Lama D, Lui SKL, et al
c-Met activation leads to the establishment of a TGFbeta-receptor regulatory network in bladder cancer progression.
Nat Commun. 2019;10:4349.
Abstract Related articles

KLEN R, Salminen AP, Mahmoudian M, Syvanen KT, et al
Prediction of complication related death after radical cystectomy for bladder cancer with machine learning methodology.
Scand J Urol. 2019 Sep 25:1-7. doi: 10.1080/21681805.2019.1665579.
Abstract Related articles

BAUMGART S, Meschkat P, Edelmann P, Heinzelmann J, et al
MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
J Cancer Res Clin Oncol. 2019 Sep 24. pii: 10.1007/s00432-019-03035.
Abstract Related articles

DATTA NR, Stutz E, Puric E, Eberle B, et al
A Pilot Study of Radiotherapy and Local Hyperthermia in Elderly Patients With Muscle-Invasive Bladder Cancers Unfit for Definitive Surgery or Chemoradiotherapy.
Front Oncol. 2019;9:889.
Abstract Related articles

ABUDUREXITI M, Xie H, Jia Z, Zhu Y, et al
Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer.
Front Oncol. 2019;9:856.
Abstract Related articles

DAZA-CAJIGAL V, Albuquerque AS, Pearson J, Hinley J, et al
Loss of Janus Associated Kinase 1 Alters Urothelial Cell Function and Facilitates the Development of Bladder Cancer.
Front Immunol. 2019;10:2065.
Abstract Related articles

BOCHNER BH
Lymph Node Dissection for Advanced Bladder Cancer: Is There a Role?
Eur Urol Focus. 2019 Sep 21. pii: S2405-4569(19)30284.
Abstract Related articles

PARIKH RB, Adamson BJS, Khozin S, Galsky MD, et al
Association Between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer.
JAMA. 2019;322:1209-1211.
Abstract Related articles

HOU G, Xu W, Jin Y, Wu J, et al
MiRNA-217 accelerates the proliferation and migration of bladder cancer via inhibiting KMT2D.
Biochem Biophys Res Commun. 2019 Sep 20. pii: S0006-291X(19)31750.
Abstract Related articles

LUO Y, Dong Y, Liang S, Yuan L, et al
CpG Oligodeoxynucleotide Promotes Apoptosis of Human Bladder Cancer T24 Cells Via Inhibition of the Antiapoptotic Factors.
Technol Cancer Res Treat. 2019;18:1533033819873636.
Abstract Related articles

LI W, Li Y, Sun Z, Zhou J, et al
Comprehensive circular RNA profiling reveals the regulatory role of the hsa_circ_0137606/miR1231 pathway in bladder cancer progression.
Int J Mol Med. 2019 Sep 17. doi: 10.3892/ijmm.2019.4340.
Abstract Related articles

YANG C, Sun X, Wang H, Lu T, et al
Metabolomic profiling identifies novel biomarkers and mechanisms in human bladder cancer treated with submucosal injection of gemcitabine.
Int J Mol Med. 2019 Sep 23. doi: 10.3892/ijmm.2019.4347.
Abstract Related articles

SHAN L, Liu W, Zhan Y
Sulfated polysaccharide of Sepiella maindroni ink targets Akt and overcomes resistance to the FGFR inhibitor AZD4547 in bladder cancer.
Aging (Albany NY). 2019;11.
Abstract Related articles

LIU Y, Xiong S, Liu S, Chen J, et al
Analysis of Gene Expression in Bladder Cancer: Possible Involvement of Mitosis and Complement and Coagulation Cascades Signaling Pathway.
J Comput Biol. 2019 Sep 23. doi: 10.1089/cmb.2019.0237.
Abstract Related articles

MORINAGA R, Kawahara T, Kuroda S, Inayama Y, et al
Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer.
Case Rep Oncol. 2019;12:603-607.
Abstract Related articles

BHUSHAN S, Ray RS, Prakash J, Singh GN, et al
Global Versus Indian Perspective of Pioglitazone-induced Adverse Drug Reactions Including Bladder Cancer: A Comparative Retrospective Pharmacovigilance Analysis.
Clin Ther. 2019 Sep 19. pii: S0149-2918(19)30422.
Abstract Related articles

ORTIZ-BRUCHLE N, Muders M, Toma M, Esposito I, et al
[Status of the availability and use of next generation sequencing (NGS) in bladder cancer-a questionnaire within the uropathology working group].
Urologe A. 2019 Sep 20. pii: 10.1007/s00120-019-01046.
Abstract Related articles

HU X, Xiong SC, Dou WC, Shao YX, et al
Minimally invasive vs open radical cystectomy in patients with bladder cancer: A systematic review and meta-analysis of randomized controlled trials.
Eur J Surg Oncol. 2019 Sep 13. pii: S0748-7983(19)30808.
Abstract Related articles

JANISCH F, Yu H, Vetterlein MW, Dahlem R, et al
Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes?
J Clin Med. 2019;8.
Abstract Related articles

MOSCHINI M, Stabile A, Mattei A, Montorsi F, et al
Enhanced recovery after surgery (ERAS) in radical cystectomy patients: from consensus to evidences.
Int Braz J Urol. 2019;45:655-657.
Abstract Related articles

BASATAC C, Aktepe F, Saglam S, Akpinar H, et al
Synchronous presentation of muscle-invasive urothelial carcinoma of bladder and peritoneal malign mesothelioma.
Int Braz J Urol. 2019;45:843-846.
Abstract Related articles

CASTELLANI D, Gasparri L, Claudini R, Pavia MP, et al
Iatrogenic foreign body in urinary bladder: Holmium laser vs. Ceramic, and the winner is....
Int Braz J Urol. 2019;45:853.
Abstract Related articles

LI D, Jiao W, Liang Z, Wang L, et al
Variation in energy metabolism arising from the effect of the tumor microenvironment on cell biological behaviors of bladder cancer cells and endothelial cells.
Biofactors. 2019 Oct 3. doi: 10.1002/biof.1568.
Abstract Related articles

LIU J, Zhang Y, Zeng Q, Zeng H, et al
Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes.
Sci Adv. 2019;5:eaaw6499.
Abstract Related articles

SIMON M, Elkayam N, Smerling J, Marcelin M, et al
Opportunistic Disease or Metastatic Lesions: A Rare Finding in a Patient with Bladder Cancer.
Curr Urol. 2019;13:54-56.
Abstract Related articles

BARRY KH, Jones RR, Cantor KP, Freeman LEB, et al
Ingested nitrate and nitrite and bladder cancer in Northern New England.
Epidemiology. 2019 Sep 30. doi: 10.1097/EDE.0000000000001112.
Abstract Related articles

HUANG Y, Wang H, Fu S, Luan T, et al
Association of rs8444 polymorphism in the LASS2 3'-UTR and bladder cancer risk in Chinese population.
Eur J Cancer Prev. 2019 Oct 1. doi: 10.1097/CEJ.0000000000000551.
Abstract Related articles

LIAO S, Ou M, Lai L, Lin H, et al
Integrated analysis of quantitative proteome and transcriptional profiles reveals abnormal gene expression and signal pathway in bladder cancer.
Genes Genomics. 2019 Oct 1. pii: 10.1007/s13258-019-00868.
Abstract Related articles

MAO F, Niu XB, Gu S, Ji L, et al
The association between matrix metalloproteinase-7 genetic variant and bladder cancer risk in a Chinese Han population.
Clin Exp Med. 2019 Oct 1. pii: 10.1007/s10238-019-00582.
Abstract Related articles

ZHOU HQ, Liu MS, Deng TB, Xie PB, et al
The TGF-beta/Smad Pathway Inhibitor SB431542 Enhances The Antitumor Effect Of Radiofrequency Ablation On Bladder Cancer Cells.
Onco Targets Ther. 2019;12:7809-7821.
Abstract Related articles

QUAN Y, Lei H, Wahafu W, Liu Y, et al
Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer.
Biomed Pharmacother. 2019;120:109490.
Abstract Related articles

MAKBOUL M, Farghaly S, Abdelkawi IF
Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.
Br J Radiol. 2019 Oct 1:20190401. doi: 10.1259/bjr.20190401.
Abstract Related articles

FU W, Wu X, Yang Z, Mi H, et al
The effect of miR-124-3p on cell proliferation and apoptosis in bladder cancer by targeting EDNRB.
Arch Med Sci. 2019;15:1154-1162.
Abstract Related articles

HAN N, Yuan F, Xian P, Liu N, et al
GADD45a Mediated Cell Cycle Inhibition Is Regulated By P53 In Bladder Cancer.
Onco Targets Ther. 2019;12:7591-7599.
Abstract Related articles

ALANEE S, Deebajah M, Chen PI, Mora R, et al
Using adaptive genetic algorithms combined with high sensitivity single cell-based technology to detect bladder cancer in urine and provide a potential noninvasive marker for response to anti-PD1 immunotherapy.
Urol Oncol. 2019 Sep 27. pii: S1078-1439(19)30351.
Abstract Related articles

LIN YH, Hou CP, Juang HH, Chang PL, et al
Association between Bladder Outlet Obstruction and Bladder Cancer in Patients with Aging Male.
J Clin Med. 2019;8.
Abstract Related articles

YANG D, Ma Y, Zhao P, Ma J, et al
Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancer.
Biomed Pharmacother. 2019;120:109433.
Abstract Related articles

LIU F, Liu A, Lu X, Zhang Z, et al
Dysbiosis signatures of the microbial profile in tissue from bladder cancer.
Cancer Med. 2019 Sep 30. doi: 10.1002/cam4.2419.
Abstract Related articles

CHI Q, Wang ZY, Li HY, Song DB, et al
Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
Chin Med J (Engl). 2019 Sep 17. doi: 10.1097/CM9.0000000000000455.
Abstract Related articles

SHI J, Zhang P, Liu L, Min X, et al
Weighted gene coexpression network analysis identifies a new biomarker of CENPF for prediction disease prognosis and progression in nonmuscle invasive bladder cancer.
Mol Genet Genomic Med. 2019 Sep 30:e982. doi: 10.1002.
Abstract Related articles

LIU X, Zhang X, Bi J, Li Z, et al
Caspase recruitment domain family member 10 regulates carbamoyl phosphate synthase 1 and promotes cancer growth in bladder cancer cells.
J Cell Mol Med. 2019 Sep 29. doi: 10.1111/jcmm.14683.
Abstract Related articles

TETTEH-QUARCOO PB, Akuetteh BK, Owusu IA, Quayson SE, et al
Cytological and Wet Mount Microscopic Observations Made in Urine of Schistosoma haematobium-Infected Children: Hint of the Implication in Bladder Cancer.
Can J Infect Dis Med Microbiol. 2019;2019:7912186.
Abstract Related articles

WU X, Xu Q, Chen P, Yu C, et al
Effect of SMYD3 on biological behavior and H3K4 methylation in bladder cancer.
Cancer Manag Res. 2019;11:8125-8133.
Abstract Related articles

DI MASO M, Turati F, Bosetti C, Montella M, et al
Food consumption, meat cooking methods and diet diversity and the risk of bladder cancer.
Cancer Epidemiol. 2019;63:101595.
Abstract Related articles

YANG X, Wang P
MiR-188-5p and MiR-141-3p influence prognosis of bladder cancer and promote bladder cancer synergistically.
Pathol Res Pract. 2019 Aug 17:152598. doi: 10.1016/j.prp.2019.152598.
Abstract Related articles

GRIMBERG DC, Shah A, Inman BA
Overview of Taris GemRIS, a Novel Drug Delivery System for Bladder Cancer.
Eur Urol Focus. 2019 Sep 24. pii: S2405-4569(19)30282.
Abstract Related articles

ALBARGHOUTH MH, Hamza A
[The impact of using intraoperative photodynamic diagnosis on the prognosis of bladder cancer].
Aktuelle Urol. 2019 Sep 26. doi: 10.1055/a-1007-8497.
Abstract Related articles

YANG L, Li YL, Li XQ, Zhang Z, et al
Corrigendum to "High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer".
Dis Markers. 2019;2019:5974238.
Abstract Related articles

APOLO AB
Determining superior first-line therapy in metastatic bladder cancer.
Nat Rev Urol. 2019 Sep 26. pii: 10.1038/s41585-019-0245.
Abstract Related articles

WYLIE H, Cahill F, Santaolalla A, Moss CL, et al
Graham Roberts Study protocol: first 'trials within cohort study' for bladder cancer.
BMJ Open. 2019;9:e029468.
Abstract Related articles

ENIKEEV DV, Alyaev YG, Rapoport LM, Taratkin MS, et al
[Multidisciplinary approach in urology. Laser technologies: faster, simpler, more efficient].
Urologiia. 2019;.
Abstract Related articles

LI G, Sun L, Mu Z, Liu S, et al
MicroRNA-1298-5p inhibits cell proliferation and invasion of bladder cancer via downregulating connexin 43.
Biochem Cell Biol. 2019 Oct 10. doi: 10.1139/bcb-2019-0137.
Abstract Related articles

BURGESS EF, Livasy C, Trufan S, Hartman A, et al
High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy.
Urol Oncol. 2019 Oct 6. pii: S1078-1439(19)30360.
Abstract Related articles

PAPADIMITRIOU MA, Avgeris M, Levis PK, Tokas T, et al
DeltaNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression.
J Cancer Res Clin Oncol. 2019 Oct 8. pii: 10.1007/s00432-019-03028.
Abstract Related articles

LIU A, Xue Y, Liu F, Tan H, et al
Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy.
Cancer Biomark. 2019 Sep 27. pii: CBM182143. doi: 10.3233/CBM-182143.
Abstract Related articles

CHEN C, Luo Y, He W, Zhao Y, et al
Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer.
J Clin Invest. 2019 Oct 8. pii: 130892. doi: 10.1172/JCI130892.
Abstract Related articles

ZHOU Q, Chen S, Lu M, Luo Y, et al
EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/beta-catenin signaling pathway in human bladder cancer.
Int J Biol Sci. 2019;15:2139-2155.
Abstract Related articles

PARK C, Cha HJ, Choi EO, Lee H, et al
Isorhamnetin Induces Cell Cycle Arrest and Apoptosis Via Reactive Oxygen Species-Mediated AMP-Activated Protein Kinase Signaling Pathway Activation in Human Bladder Cancer Cells.
Cancers (Basel). 2019;11.
Abstract Related articles

CHESTNUT C, Smelser W, Dum T, Bechtel M, et al
Glycemic impact of a diet and lifestyle intervention on diabetics and prediabetics during treatment for non-muscle invasive bladder cancer.
Nutr Cancer. 2019 Oct 7:1-6. doi: 10.1080/01635581.2019.1672761.
Abstract Related articles

GRONOSTAJ K, Czech AK, Fronczek J, Drobniak A, et al
The Prognostic Value of Tumor Regression Grades Combined With TNM Classification in Patients With Muscle-Invasive Bladder Cancer Who Underwent Neoadjuvant Chemotherapy Followed by Radical Cystectomy.
Clin Genitourin Cancer. 2019 Sep 12. pii: S1558-7673(19)30272.
Abstract Related articles

TSAI TF, Chen PC, Lin YC, Chou KY, et al
Benzyl isothiocyanate promotes miR-99a expression through ERK/AP-1-dependent pathway in bladder cancer cells.
Environ Toxicol. 2019 Oct 6. doi: 10.1002/tox.22841.
Abstract Related articles

ROUDAFSHANI Z, Jazayeri MH, Mahmoudi AR, Nedaeinia R, et al
Evaluation of the frequency of CD5(+) B cells as natural immunoglobulin M producers and circulating soluble CD5 in patients with bladder cancer.
Mol Biol Rep. 2019 Oct 5. pii: 10.1007/s11033-019-05087.
Abstract Related articles

CARRION A, Huguet J, Ribal MJ, Dominguez A, et al
Comparison of standard vs. palliative management for bladder cancer in patients older than 85 years: multicenter study of 317 de novo tumors.
Urol Oncol. 2019 Oct 2. pii: S1078-1439(19)30358.
Abstract Related articles

GENITSCH V, Kollar A, Vandekerkhove G, Blarer J, et al
Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
Urol Oncol. 2019 Oct 1. pii: S1078-1439(19)30376.
Abstract Related articles

KASANGA TK, Ntanga DI, Musapoudi EM, Kapessa ND, et al
[Recurrent invasive bladder urothelial carcinoma treated by cystectomy with substitutive ileal enterocystoplasty: case report].
Pan Afr Med J. 2019;33:184.
Abstract Related articles

BRIENS A, Castelli J, Barateau A, Jaksic N, et al
[Adaptive radiotherapy: Strategies and benefits depending on tumor localization].
Cancer Radiother. 2019;23.
Abstract Related articles

OUEDRAOGO S, Traore MT, Kambire JL, Ouedraogo S, et al
[Primary urological cancers in a context of limited resources: Epidemiology and treatment].
Bull Cancer. 2019;106:868-874.
Abstract Related articles

BAHRAMI S, Kazemi B, Zali H, Black PC, et al
Discovering therapeutic protein targets for muscle invasive bladder cancer by proteomic data analysis.
Curr Mol Pharmacol. 2019 Oct 16. pii: CMP-EPUB-101531.
Abstract Related articles

WANG F, Cao M, Fan M, Wu H, et al
AMPK-mTOR-ULK1 axis activation-dependent autophagy promotes hydroxycamptothecin-induced apoptosis in human bladder cancer cells.
J Cell Physiol. 2019 Oct 16. doi: 10.1002/jcp.29307.
Abstract Related articles

YUAN S, Luan X, Han G, Guo K, et al
LINC01638 lncRNA mediates the postoperative distant recurrence of bladder cancer by upregulating ROCK2.
Oncol Lett. 2019;18:5392-5398.
Abstract Related articles

GRANT CM, Amdur R, Whalen MJ
Trends in the use of neoadjuvant chemotherapy for bladder cancer with nonurothelial variant histology: An analysis of the National Cancer Database.
Indian J Urol. 2019;35:291-298.
Abstract Related articles

DE GOEIJ L, Westhoff E, Witjes JA, Aben KK, et al
The UroLife study: protocol for a Dutch prospective cohort on lifestyle habits in relation to non-muscle-invasive bladder cancer prognosis and health-related quality of life.
BMJ Open. 2019;9:e030396.
Abstract Related articles

DE JONG JJ, Liu Y, Robertson AG, Seiler R, et al
Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis.
Genome Med. 2019;11:60.
Abstract Related articles

WANG B, Wang Z, Zhang T, Yang G, et al
Overexpression of thymosin beta10 correlates with disease progression and poor prognosis in bladder cancer.
Exp Ther Med. 2019;18:3759-3766.
Abstract Related articles

ZHU L, Sun J, Wang L, Li Z, et al
Prognostic and Clinicopathological Significance of PD-L1 in Patients With Bladder Cancer: A Meta-Analysis.
Front Pharmacol. 2019;10:962.
Abstract Related articles

WANG TW, Yuan H, Diao WL, Yang R, et al
Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence.
BMC Urol. 2019;19:90.
Abstract Related articles

FANG C, Xu L, He W, Dai J, et al
Long noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in bladder cancer via modulating the miR-223-HSP90B1 axis.
Cell Cycle. 2019 Oct 15:1-12. doi: 10.1080/15384101.2019.1673633.
Abstract Related articles

BORKOWSKA EM, Konecki T, Pietrusinski M, Borowiec M, et al
MicroRNAs Which Can Prognosticate Aggressiveness of Bladder Cancer.
Cancers (Basel). 2019;11.
Abstract Related articles

NITTA M, Kuroda S, Nagao K, Higure T, et al
Effect of neoadjuvant chemotherapy in patients undergoing radical cystectomy for muscle-invasive bladder cancer: a retrospective, multi-institutional study.
Jpn J Clin Oncol. 2019 Oct 15. pii: 5587304. doi: 10.1093.
Abstract Related articles

DING ZS, He YH, Deng YS, Peng PX, et al
MicroRNA-34a inhibits bladder cancer cell migration and invasion, and upregulates PTEN expression.
Oncol Lett. 2019;18:5549-5554.
Abstract Related articles

YOSHIDA T, Sopko NA, Kates M, Liu X, et al
Impact of spheroid culture on molecular and functional characteristics of bladder cancer cell lines.
Oncol Lett. 2019;18:4923-4929.
Abstract Related articles

YANG Y, Zhang F, Huang H, Xie Z, et al
Long noncoding RNA LINC00319 regulates ROMO1 expression and promotes bladder cancer progression via miR-4492/ROMO1 axis.
J Cell Physiol. 2019 Oct 14. doi: 10.1002/jcp.29271.
Abstract Related articles

CHEREMISIN D, Andropova P, Gavrilov P
Reply to: BCG infection following immunotherapy for bladder cancer.
QJM. 2019 Oct 14. pii: 5586893. doi: 10.1093.
Abstract Related articles

MOSINA N, Kayukov I
Renal tuberculosis following BCG therapy for bladder cancer.
QJM. 2019 Oct 14. pii: 5586891. doi: 10.1093.
Abstract Related articles

KOUBA E, Lopez-Beltran A, Montironi R, Massari F, et al
Liquid biopsy in the clinical management of bladder cancer: current status and future developments.
Expert Rev Mol Diagn. 2019 Oct 17:1-10. doi: 10.1080/14737159.2019.1680284.
Abstract Related articles

SZARVAS T, Olah C, Riesz P, Geczi L, et al
[Molecular subtype classification of urothelial bladder cancer and its clinical relevance].
Orv Hetil. 2019;160:1647-1654.
Abstract Related articles

LIU S, Chen Q, Wang Y
MiR-125b-5p suppresses the bladder cancer progression via targeting HK2 and suppressing PI3K/AKT pathway.
Hum Cell. 2019 Oct 11. pii: 10.1007/s13577-019-00285.
Abstract Related articles

MA W, Ma J, Lei T, Zhao M, et al
Targeting immunotherapy for bladder cancer by using anti-CD3 x CD155 bispecific antibody.
J Cancer. 2019;10:5153-5161.
Abstract Related articles

ZHOU K, Yang J, Li X, Chen W, et al
Long non-coding RNA XIST promotes cell proliferation and migration through targeting miR-133a in bladder cancer.
Exp Ther Med. 2019;18:3475-3483.
Abstract Related articles

TANG F, He Z, Lu Z, Wu W, et al
Application of nomograms in the prediction of overall survival and cancer-specific survival in patients with T1 high-grade bladder cancer.
Exp Ther Med. 2019;18:3405-3414.
Abstract Related articles

VESKIMAE E, Espinos EL, Bruins HM, Yuan Y, et al
What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology
Eur Urol Oncol. 2019 Oct 7. pii: S2588-9311(19)30144.
Abstract Related articles

MARTIN KA, Hum NR, Sebastian A, He W, et al
Methionine Adenosyltransferase 1a (MAT1A) Enhances Cell Survival During Chemotherapy Treatment and is Associated with Drug Resistance in Bladder Cancer PDX Mice.
Int J Mol Sci. 2019;20.
Abstract Related articles

UCPINAR B, Erbin A, Ayranci A, Caglar U, et al
Prediction of recurrence in non-muscle invasive bladder cancer patients. Do patient characteristics matter?
J BUON. 2019;24:1659-1665.
Abstract Related articles

CHEN L, Hu W, Li G, Guo Y, et al
Efficacy of bladder perfusion of alternating hydroxycamptothecin and gemcitabine combined with low-dose tuberculin in the treatment of non-muscle invasive bladder cancer after TURBT.
J BUON. 2019;24:1652-1658.
Abstract Related articles

WAHLIN S, Nodin B, Leandersson K, Boman K, et al
Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens.
Oncoimmunology. 2019;8:e1644108.
Abstract Related articles

WOODFORD MR, Hughes M, Sager RA, Backe SJ, et al
Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity.
Oncotarget. 2019;10:5824-5834.
Abstract Related articles

SHI H, Li J, Li K, Yang X, et al
Minimally invasive versus open radical cystectomy for bladder cancer: A systematic review and meta-analysis.
J Int Med Res. 2019;47:4604-4618.
Abstract Related articles

ZHANG N, Wang X, Wang C, Chen S, et al
Diagnostic Accuracy of Multi-Parametric Magnetic Resonance Imaging for Tumor Staging of Bladder Cancer: Meta-Analysis.
Front Oncol. 2019;9:981.
Abstract Related articles

ALDOGHACHI AF, Baharudin A, Ahmad U, Chan SC, et al
Evaluation of CERS2 Gene as a Potential Biomarker for Bladder Cancer.
Dis Markers. 2019;2019:3875147.
Abstract Related articles

SATO G, Yoshida T, Yanishi M, Saito R, et al
Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
Clin Genitourin Cancer. 2019 Sep 27. pii: S1558-7673(19)30286.
Abstract Related articles

SIDDIQUI Z, Srivastava AN, Sankhwar SN, Zaidi N, et al
Oct-4: a prognostic biomarker of urinary bladder cancer in North India.
Ther Adv Urol. 2019;11:1756287219875576.
Abstract Related articles

WU ZS, Ding W, Cai J, Bashir G, et al
Communication Of Cancer Cells And Lymphatic Vessels In Cancer: Focus On Bladder Cancer.
Onco Targets Ther. 2019;12:8161-8177.
Abstract Related articles

WANG RJ, Liu W, Mu XY, Yao ZX, et al
Preoperative CD4(+)CD25(+)/CD4(+) and tumor diameter predict prognosis in male patients with bladder cancer.
Biomark Med. 2019;13:1387-1397.
Abstract Related articles

LI WM, Wu WJ
Transgelin in bladder cancer: A potential biomarker and therapeutic target.
EBioMedicine. 2019 Oct 17. pii: S2352-3964(19)30609.
Abstract Related articles

FERNANDEZ MI, Valdebenito P, Delgado I, Segebre J, et al
Impact of arsenic exposure on clinicopathological characteristics of bladder cancer: A comparative study between patients from an arsenic-exposed region and nonexposed reference sites.
Urol Oncol. 2019 Oct 17. pii: S1078-1439(19)30364.
Abstract Related articles

FUKUOKAYA W, Kimura T, Miki J, Kimura S, et al
Effectiveness of Intravesical Doxorubicin Immediately Following Resection of Primary Non-muscle-invasive Bladder Cancer: A Propensity Score-matched Analysis.
Clin Genitourin Cancer. 2019 Sep 27. pii: S1558-7673(19)30274.
Abstract Related articles

VOSKUILEN CS, Bosschieter J, van Werkhoven E, Hendricksen K, et al
Long-term survival and complications following bladder-preserving brachytherapy in patients with cT1-T2 bladder cancer.
Radiother Oncol. 2019 Oct 17. pii: S0167-8140(19)33115.
Abstract Related articles

FARAJ K, Chang YH, Rose KM, Habermann EB, et al
Single-dose perioperative mitomycin-C versus thiotepa for low-grade noninvasive bladder cancer.
Can J Urol. 2019;26:9922-9930.
Abstract Related articles

CHEN C, Huang H, Zhao Y, Liu H, et al
Diagnostic performance of image technique based transurethral resection for non-muscle invasive bladder cancer: systematic review and diagnostic meta-analysis.
BMJ Open. 2019;9:e028173.
Abstract Related articles

NGUYEN HT, Shah ZK, Mortazavi A, Pohar KS, et al
Periodically rotated overlapping parallel lines with enhanced reconstruction acquisition to improve motion-induced artifacts in bladder cancer imaging: Initial findings.
Medicine (Baltimore). 2019;98:e17075.
Abstract Related articles

FUJIMI A, Nagamachi Y, Yamauchi N, Tamura F, et al
Gastrointestinal Stromal Tumor in a Patient with Neurofibromatosis Type 1 That Was Successfully Treated with Regorafenib.
Intern Med. 2019;58:1865-1870.
Abstract Related articles

YANG G, Liu M, Liu Q, Duan X, et al
Granulocytic myeloid-derived suppressor cells correlate with outcomes undergoing neoadjuvant chemotherapy for bladder cancer.
Urol Oncol. 2019 Oct 28. pii: S1078-1439(18)30235.
Abstract Related articles

FURUYA H, Pagano I, Chee K, Kobayashi T, et al
Comparison of Commercial ELISA Kits, a Prototype Multiplex Electrochemoluminescent Assay, and a Multiplex Bead-Based Immunoassay for Detecting a Urine-Based Bladder-Cancer-Associated Diagnostic Signature.
Diagnostics (Basel). 2019;9.
Abstract Related articles

DE KEUKELEIRE S, De Maeseneer D, Jacobs C, Rottey S, et al
Targeting FGFR in bladder cancer: ready for clinical practice?
Acta Clin Belg. 2019 Oct 31:1-8. doi: 10.1080/17843286.2019.1685738.
Abstract Related articles

APOLO AB, Milowsky MI, Kim L, Inman BA, et al
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer.
JAMA Oncol. 2019 Oct 31:1-9. doi: 10.1001/jamaoncol.2019.4114.
Abstract Related articles

WANG Y, Shen Y, Hu X, Li Z, et al
Application of R2* and Apparent Diffusion Coefficient in Estimating Tumor Grade and T Category of Bladder Cancer.
AJR Am J Roentgenol. 2019 Oct 31:1-7. doi: 10.2214/AJR.19.21668.
Abstract Related articles

RUSSELL B, Liedberg F, Khan MS, Nair R, et al
A Systematic Review and Meta-analysis of Delay in Radical Cystectomy and the Effect on Survival in Bladder Cancer Patients.
Eur Urol Oncol. 2019 Oct 23. pii: S2588-9311(19)30151.
Abstract Related articles

BRAICU C, Buiga R, Cojocneanu R, Buse M, et al
Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression.
J Exp Clin Cancer Res. 2019;38:433.
Abstract Related articles

ALJABERY F, Liedberg F, Haggstrom C, Strock V, et al
Management and outcome of muscle-invasive bladder cancer with clinical lymph node metastases. A nationwide population-based study in the bladder cancer data base Sweden (BladderBaSe).
Scand J Urol. 2019 Oct 30:1-7. doi: 10.1080/21681805.2019.1681504.
Abstract Related articles

WANG R, Yan Y, Liu S, Yao X, et al
Comparison of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Bladder Cancer Patients Undergoing Radical Cystectomy.
Biomed Res Int. 2019;2019:3628384.
Abstract Related articles

TEY J, Soon YY, Cheo T, Ooi KH, et al
Efficacy of Palliative Bladder Radiotherapy for Hematuria in Advanced Bladder Cancer Using Contemporary Radiotherapy Techniques.
In Vivo. 2019;33:2161-2167.
Abstract Related articles

LIU YC, Lin KH, Hsieh JH, Chung JG, et al
Hyperforin Induces Apoptosis Through Extrinsic/Intrinsic Pathways and Inhibits NF-kB-modulated Survival and Invasion Potential in Bladder Cancer.
In Vivo. 2019;33:1865-1877.
Abstract Related articles

SUN N, Liang Y, Chen Y, Wang L, et al
Glutamine affects T24 bladder cancer cell proliferation by activating STAT3 through ROS and glutaminolysis.
Int J Mol Med. 2019 Oct 25. doi: 10.3892/ijmm.2019.4385.
Abstract Related articles

CAO R, Yuan L, Ma B, Wang G, et al
An EMT-related gene signature for the prognosis of human bladder cancer.
J Cell Mol Med. 2019 Oct 28. doi: 10.1111/jcmm.14767.
Abstract Related articles

JAIN H, Gada K, Zaidi S, Asiago-Reddy E, et al
Mycobacterium bovis epidural abscess following Bacillus Calmette-Guerin therapy for bladder cancer.
Proc (Bayl Univ Med Cent). 2019;32:577-578.
Abstract Related articles

DONG F, Chen L, Wang R, Yang W, et al
4-nitrophenol exposure in T24 human bladder cancer cells promotes proliferation, motilities and epithelial-to-mesenchymal transition.
Environ Mol Mutagen. 2019 Oct 26. doi: 10.1002/em.22345.
Abstract Related articles

QUERIDO S, Fernandes I, Weigert A, Casimiro S, et al
High-grade urothelial carcinoma in a kidney transplant recipient after JC virus nephropathy: the first evidence of JC virus as a potential oncovirus in bladder cancer.
Am J Transplant. 2019 Oct 25. doi: 10.1111/ajt.15663.
Abstract Related articles

CHRISTOPH F, Herrmann F, Werthemann P, Janik T, et al
Ureteroenteric strictures: a single center experience comparing Bricker versus Wallace ureteroileal anastomosis in patients after urinary diversion for bladder cancer.
BMC Urol. 2019;19:100.
Abstract Related articles

KOUBA E, Cheng L
Clinical utility versus futility: a tipping point for liquid biopsies in bladder cancer.
Future Oncol. 2019 Oct 25. doi: 10.2217/fon-2019-0522.
Abstract Related articles

LIU P, Li X, Cui Y, Chen J, et al
LncRNA-MALAT1 mediates cisplatin resistance via miR-101-3p/VEGF-C pathway in bladder cancer.
Acta Biochim Biophys Sin (Shanghai). 2019 Oct 23. pii: 5603543.
Abstract Related articles

PENG M, Deng J, Zhou S, Xiao D, et al
Dual Inhibition of Pirarubicin-Induced AKT and ERK Activations by Phenformin Sensitively Suppresses Bladder Cancer Growth.
Front Pharmacol. 2019;10:1159.
Abstract Related articles

YAN D, Dong W, He Q, Yang M, et al
Circular RNA circPICALM sponges miR-1265 to inhibit bladder cancer metastasis and influence FAK phosphorylation.
EBioMedicine. 2019 Oct 21. pii: S2352-3964(19)30596.
Abstract Related articles

KISLYAKOV DA, Severgina LO, Tsarichenko DG, Rapoport LM, et al
[Novel approaches for transurethral en-bloc resection of large bladder tumors].
Urologiia. 2019;:105-111.
Abstract Related articles

DARENKOV SP, Pinchuk IS, Proskokov AA, Trofimchuk AD, et al
[Radical cystectomy: therapeutic aspects of preoperative and early postoperative management].
Urologiia. 2019;:44-50.
Abstract Related articles

HOLMANG S, Hedelin H, Malmstrom PU

Lakartidningen. 2019;116.
Abstract Related articles

ZHANG B, Fu Z, Liu L, Qiao B, et al
Non-functional paraganglioma of urinary bladder managed by transurethral resection.
Int Braz J Urol. 2019;45:910-915.
Abstract Related articles

ZHANG M, Chen Y, Cong X, Zhao X, et al
Utility of intravoxel incoherent motion MRI derived parameters for prediction of aggressiveness in urothelial bladder carcinoma.
J Magn Reson Imaging. 2018 May 8. doi: 10.1002/jmri.26165.
Abstract Related articles

FERNANDEZ-CONEJO G, de la Pena E, Hernandez V, Castro A, et al
Incidence and prognosis of clinically significant incidental prostate cancer after radical cystectomy for bladder cancer.
Arch Esp Urol. 2019;72:915-920.
Abstract Related articles

ZHANG L, Wang CZ, Ma M, Shao GF, et al
MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway.
Eur Rev Med Pharmacol Sci. 2019;23:8813-8822.
Abstract Related articles

ZHU QL, Zhan DM, Chong YK, Ding L, et al
MiR-652-3p promotes bladder cancer migration and invasion by targeting KCNN3.
Eur Rev Med Pharmacol Sci. 2019;23:8806-8812.
Abstract Related articles

XIONG M, Chen L, Zhou L, Ding Y, et al
NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
Theranostics. 2019;9:7156-7167.
Abstract Related articles

MAZZONE E, Knipper S, Mistretta FA, Palumbo C, et al
Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies.
J Natl Compr Canc Netw. 2019;17:1344-1352.
Abstract Related articles

TAE JH, Pyun JH, Shim JS, Cho S, et al
Oncological and functional outcomes of robot-assisted radical cystectomy in bladder cancer patients in a single tertiary center: Can these be preserved throughout the learning curve?
Investig Clin Urol. 2019;60:463-471.
Abstract Related articles

ZHANG C, Chang X, Chen D, Yang F, et al
Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway.
Cancer Manag Res. 2019;11:7909-7923.
Abstract Related articles

DE NUNZIO C, Giannatempo P, Passalacqua R, Fiorini E, et al
Epidemiology and unmet needs of bladder cancer in Italy: a critical review.
Minerva Urol Nefrol. 2019 Nov 4. pii: S0393-2249.19.03498.
Abstract Related articles

YAO J, Zhang Z, Li S, Li B, et al
Melittin inhibits proliferation, migration and invasion of bladder cancer cells by regulating key genes based on bioinformatics and experimental assays.
J Cell Mol Med. 2019 Nov 5. doi: 10.1111/jcmm.14775.
Abstract Related articles

HURLE R, Casale P, Saita A, Colombo P, et al
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) proj
World J Urol. 2019 Nov 5. pii: 10.1007/s00345-019-03002.
Abstract Related articles

ZHANG Y, Hong YK, Zhuang DW, He XJ, et al
Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
Medicine (Baltimore). 2019;98:e17725.
Abstract Related articles

LI Z, Wei D, Zhu C, Zhang Q, et al
Effect of a patient education and rehabilitation program on anxiety, depression and quality of life in muscle invasive bladder cancer patients treated with adjuvant chemotherapy.
Medicine (Baltimore). 2019;98:e17437.
Abstract Related articles

ALLEN BC, Oto A, Akin O, Alexander LF, et al
ACR Appropriateness Criteria(R) Post-Treatment Surveillance of Bladder Cancer.
J Am Coll Radiol. 2019;16.
Abstract Related articles

YU H, Wu CL, Wang X, Ban Q, et al
SP600125 enhances C-2-induced cell death by the switch from autophagy to apoptosis in bladder cancer cells.
J Exp Clin Cancer Res. 2019;38:448.
Abstract Related articles

BOUBAKER NS, Gurtner A, Trabelsi N, Manni I, et al
Evaluating prognostic utility of preoperative Neutrophil to Lymphocyte Ratio and hsa-let-7g/c up-regulation in patients with urinary bladder cancer.
Cancer Biomark. 2019 Oct 25. pii: CBM190483. doi: 10.3233/CBM-190483.
Abstract Related articles

HWANG B, Shin SS, Song JH, Choi YH, et al
Carnosine exerts antitumor activity against bladder cancers in vitro and in vivo via suppression of angiogenesis.
J Nutr Biochem. 2019;74:108230.
Abstract Related articles

LIPUNOVA N, Wesselius A, Cheng KK, van Schooten FJ, et al
External Replication of Urinary Bladder Cancer Prognostic Polymorphisms in the UK Biobank.
Front Oncol. 2019;9:1082.
Abstract Related articles

WANG Y, Chen L, Ju L, Qian K, et al
Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis.
Front Oncol. 2019;9:1030.
Abstract Related articles

WENTLAND AL, Desser TS, Troxell ML, Kamaya A, et al
Bladder cancer and its mimics: a sonographic pictorial review with CT/MR and histologic correlation.
Abdom Radiol (NY). 2019 Nov 1. pii: 10.1007/s00261-019-02276.
Abstract Related articles

RICHTERS A, Aben KKH, Kiemeney LALM
The global burden of urinary bladder cancer: an update.
World J Urol. 2019 Nov 1. pii: 10.1007/s00345-019-02984.
Abstract Related articles

KAUSHIK D, Shi Z, Liss MA, Wang H, et al
Screening logs from a pilot randomized controlled trial of radical cystectomy versus chemoradiation therapy for muscle-invasive bladder cancer.
Urol Oncol. 2019 Oct 29. pii: S1078-1439(19)30359.
Abstract Related articles

BLACK AJ, Zargar H, Zargar-Shoshtari K, Fairey AS, et al
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.
Urol Oncol. 2019 Oct 29. pii: S1078-1439(19)30374.
Abstract Related articles

JIANG C, Zhao W, Qin M, Jin M, et al
CD56-chimeric antigen receptor T-cell therapy for refractory/recurrent rhabdomyosarcoma: A 3.5-year follow-up case report.
Medicine (Baltimore). 2019;98:e17572.
Abstract Related articles

TATEOKA J, Wada N, Tamaki G, Kikuchi D, et al
[A Case of Adenocarcinoma of the Reconstructed Bladder 45 Years after Ileocystoplasty].
Hinyokika Kiyo. 2019;65:305-308.
Abstract Related articles

CAI H, Yang X, Gao Y, Xu Z, et al
Exosomal MicroRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer.
Mol Ther Nucleic Acids. 2019;18:787-800.
Abstract Related articles

WAHAFU W, Liu S, Xu W, Wang M, et al
The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching study.
BMC Urol. 2019;19:117.
Abstract Related articles

KOCSMAR I, Pajor G, Gyongyosi B, Szekely E, et al
Development and Initial Testing of a Modified UroVysion-Based Fluorescence In Situ Hybridization Score for Prediction of Progression in Bladder Cancer.
Am J Clin Pathol. 2019 Nov 16. pii: 5626496. doi: 10.1093.
Abstract Related articles

BALBAY MD, Canda AE, Kiremit MC, Koseoglu E, et al
Intracorporeal Studer pouch formation with Balbay's technique following robotic radical cystectomy for bladder cancer: Experience with 22 cases with oncologic and functional outcomes.
J Endourol. 2019 Nov 15. doi: 10.1089/end.2019.0559.
Abstract Related articles

LIN GB, Zhang CM, Chen XY, Wang JW, et al
Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer.
Math Biosci Eng. 2019;17:834-844.
Abstract Related articles

RASSY E, Assi T, Kattan J
Is there a role for maintenance therapy after platinum chemotherapy in bladder cancer in the era of immune therapy?
Future Oncol. 2019 Nov 15. doi: 10.2217/fon-2019-0542.
Abstract Related articles

ZHU D, Li H
Case Study: Landscape of Chimeric RNAs in Bladder Cancer.
Methods Mol Biol. 2020;2079:233-241.
Abstract Related articles

TAO K, Liu S, Wang L, Qiu H, et al
Targeted multifunctional nanomaterials with MRI, chemotherapy and photothermal therapy for the diagnosis and treatment of bladder cancer.
Biomater Sci. 2019 Nov 14. doi: 10.1039/c9bm01377.
Abstract Related articles

KIM A, Kim MS, Ahn JH, Choi WS, et al
Clinical significance of 5-alpha reductase inhibitor and androgen deprivation therapy in bladder cancer incidence, recurrence, and survival: a meta-analysis and systemic review.
Aging Male. 2019 Nov 14:1-8. doi: 10.1080/13685538.2019.1646238.
Abstract Related articles

MEHROTRA S, Rowland M, Zhang H, Russell B, et al
Scoping review protocol: is there a role for physical activity interventions in the treatment pathway of bladder cancer?
BMJ Open. 2019;9:e033518.
Abstract Related articles

QI Y, Chang Y, Wang Z, Chen L, et al
Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response.
Cancer Immunol Immunother. 2019 Nov 12. pii: 10.1007/s00262-019-02429.
Abstract Related articles

CZECH AK, Gronostaj K, Frydrych J, Fronczek J, et al
Identification of potential prognostic factors for absence of residual disease in the second resection of T1 bladder cancer.
Cent European J Urol. 2019;72:252-257.
Abstract Related articles

STROMYER ML, Southerland MR, Satyal U, Sikder RK, et al
Synthesis, characterization, and biological activity of a triphenylphosphonium-containing imidazolium salt against select bladder cancer cell lines.
Eur J Med Chem. 2019 Oct 31:111832. doi: 10.1016/j.ejmech.2019.111832.
Abstract Related articles

SIDDIQUI Z, Srivastava AN, Sankhwar SN, Dalela D, et al
Synergic effects of cancer stem cells markers, CD44 and embryonic stem cell transcription factor Nanog, on bladder cancer prognosis.
Br J Biomed Sci. 2019 Nov 13. pii: 10.1080/09674845.2019.1692761.
Abstract Related articles

LIU MK, Ma T, Yu Y, Suo Y, et al
MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer.
Technol Cancer Res Treat. 2019;18:1533033819886897.
Abstract Related articles

ROSIELLO G, Knipper S, Palumbo C, Pecoraro A, et al
Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion.
Clin Genitourin Cancer. 2019 Oct 17. pii: S1558-7673(19)30316.
Abstract Related articles

LEO MC, McMullen CK, O'Keeffe-Rosetti M, Weinmann S, et al
External validation of the EORTC and NCCN bladder cancer recurrence and progression risk calculators in a U.S. community-based health system.
Urol Oncol. 2019 Nov 8. pii: S1078-1439(19)30404.
Abstract Related articles

MOTTERLE G, Andrews JR, Morlacco A, Karnes RJ, et al
Predicting Response to Neoadjuvant Chemotherapy in Bladder Cancer.
Eur Urol Focus. 2019 Nov 7. pii: S2405-4569(19)30338.
Abstract Related articles

LI W, Li Y, Ma W, Zhou J, et al
Long noncoding RNA AC114812.8 promotes the progression of bladder cancer through miR-371b-5p/FUT4 axis.
Biomed Pharmacother. 2019;121:109605.
Abstract Related articles

REIS H, Szarvas T
[Predictive biomarkers in bladder cancer].
Pathologe. 2019 Nov 8. pii: 10.1007/s00292-019-00688.
Abstract Related articles

SIM WJ, Iyengar PV, Lama D, Lui SKL, et al
Author Correction: c-Met activation leads to the establishment of a TGFbeta-receptor regulatory network in bladder cancer progression.
Nat Commun. 2019;10:5148.
Abstract Related articles

MORII Y, Osawa T, Suzuki T, Shinohara N, et al
Cost comparison between open radical cystectomy, laparoscopic radical cystectomy, and robot-assisted radical cystectomy for patients with bladder cancer: a systematic review of segmental costs.
BMC Urol. 2019;19:110.
Abstract Related articles

NGUYEN EK, Yu H, Pond G, Shayegan B, et al
Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer.
Can Urol Assoc J. 2019 Nov 5. pii: cuaj.5945. doi: 10.5489/cuaj.5945.
Abstract Related articles

ZHANG W, Wang R, Ma W, Wu Y, et al
Systemic immune-inflammation index predicts prognosis of bladder cancer patients after radical cystectomy.
Ann Transl Med. 2019;7:431.
Abstract Related articles

WANG QH, Ji JL, Li H, He PL, et al
[Preoperative Lymphocyte-to-monocyte Ratio Predicts Prognosis in Patients with Stage T1 Non-muscle Invasive Bladder Cancer].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019;41:622-629.
Abstract Related articles

ZHANG Y, Wang Y, Song B, Li H, et al
Patients' self-report anxiety, depression and quality of life and their predictive factors in muscle invasive bladder cancer patients receiving adjuvant chemotherapy.
Psychol Health Med. 2019 Nov 8:1-11. doi: 10.1080/13548506.2019.1687912.
Abstract Related articles

TAN S, Kang Y, Li H, Zheng L, et al
[Early complications after robot-assisted laparoscopic radical cystectomy and their risk factors].
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019;44:1003-1008.
Abstract Related articles

TOKURA T, Watanabe N, Morita T
[A Case of Urachal Cancer at the Inserted Site of Cystostomy after 23 Years].
Gan To Kagaku Ryoho. 2019;46:1656-1658.
Abstract Related articles

RAMIREZ BACKHAUS M, Calatrava-Fons A, Gomez-Ferrer A, Collado-Serra A, et al
[ICG lymphography and fluorescence in pelvic lymphadenectomy for bladder and prostate cancer.]
Arch Esp Urol. 2019;72:831-841.
Abstract Related articles

LUZZAGO S, Palumbo C, Rosiello G, Pecoraro A, et al
The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder.
J Surg Oncol. 2019;120:1266-1275.
Abstract Related articles

ANAND V, Khandelwal M, Appunni S, Gupta N, et al
CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach.
J Cancer Res Clin Oncol. 2019;145:2649-2661.
Abstract Related articles

YOON HY, Chang IH, Goo YT, Kim CH, et al
Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel.
Int J Nanomedicine. 2019;14:6249-6268.
Abstract Related articles

BILLGER M, Kirk J, Chang J, Bedard A, et al
Response to letter from Dr Oliviera in relation to our publication: A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.
Regul Toxicol Pharmacol. 2019;106:347-348.
Abstract Related articles

OLIVEIRA PA, Seixas F
Re: A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.
Regul Toxicol Pharmacol. 2019;106:346.
Abstract Related articles

MEUNIER ME, Neuzillet Y, Raynaud JP, Radulescu C, et al
Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial).
Prostate. 2019;79:272-280.
Abstract Related articles

ZALESKI M, Gogoj A, Walter V, Raman JD, et al
Mitotic activity in noninvasive papillary urothelial carcinoma: its value in predicting tumor recurrence and comparison with the contemporary 2-tier grading system.
Hum Pathol. 2019;84:275-282.
Abstract Related articles

BARRESI V, Nunnari CM, Lionti S
Immunohistochemical stains to detect residual tumor in cystectomy specimens taken shortly after transurethral resection of bladder tumors.
Ann Diagn Pathol. 2019;40:176-179.
Abstract Related articles

LI M, Liu Y, Liu J, Li W, et al
Circ_0006332 promotes growth and progression of bladder cancer by modulating MYBL2 expression via miR-143.
Aging (Albany NY). 2019;11.
Abstract Related articles

LARSEN ES, Joensen UN, Poulsen AM, Goletti D, et al
Bacillus Calmette-Guerin immunotherapy for bladder cancer: A review of immunological aspects, clinical effects and BCG infections.
APMIS. 2019 Nov 22. doi: 10.1111/apm.13011.
Abstract Related articles

BASU A, Sadeghi S
Neoadjuvant Therapies for Bladder Cancer in Cisplatin-ineligible Patients: What Options Do We Have?
Eur Urol Focus. 2019 Nov 18. pii: S2405-4569(19)30339.
Abstract Related articles

YAN L, Wang P, Fang W, Liang C, et al
Cancer-associated fibroblasts-derived exosomes-mediated transfer of LINC00355 regulates bladder cancer cell proliferation and invasion.
Cell Biochem Funct. 2019 Nov 21. doi: 10.1002/cbf.3462.
Abstract Related articles

ZHANG WY, Liu QH, Wang TJ, Zhao J, et al
CircZFR serves as a prognostic marker to promote bladder cancer progression by regulating miR-377/ZEB2 signaling.
Biosci Rep. 2019 Nov 20. pii: 221189. doi: 10.1042/BSR20192779.
Abstract Related articles

WASEDA Y, Kobayashi S, Kanda E, Yokoyama M, et al
Impact of Bladder Neck Involvement on Recurrence in Patients With Non-muscle-invasive Bladder Cancer: An Analysis Based on a Time-dependent Model.
Clin Genitourin Cancer. 2019 Oct 16. pii: S1558-7673(19)30309.
Abstract Related articles

AL-AHMADIE H, Netto GJ
Updates on the Genomics of Bladder Cancer and Novel Molecular Taxonomy.
Adv Anat Pathol. 2019 Nov 14. doi: 10.1097/PAP.0000000000000252.
Abstract Related articles

HECHLER V, Rink M, Beyersdorff D, Beer M, et al
[The role of the vesical imaging-reporting and data system (VI-RADS) for bladder cancer diagnostics-status quo].
Urologe A. 2019 Nov 18. pii: 10.1007/s00120-019-01061.
Abstract Related articles

HORWICH A, Babjuk M, Bellmunt J, Bruins HM, et al
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committeesdagger.
Ann Oncol. 2019 Nov 19. pii: 5629133. doi: 10.1093.
Abstract Related articles

PAN S, Zhan Y, Chen X, Wu B, et al
Bladder Cancer Exhibiting High Immune Infiltration Shows the Lowest Response Rate to Immune Checkpoint Inhibitors.
Front Oncol. 2019;9:1101.
Abstract Related articles

CHEN S, Zhang N, Shao J, Wang T, et al
A novel gene signature combination improves the prediction of overall survival in urinary bladder cancer.
J Cancer. 2019;10:5744-5753.
Abstract Related articles

SONG BN, Kim SK, Mun JY, Choi YD, et al
Identification of an immunotherapy-responsive molecular subtype of bladder cancer.
EBioMedicine. 2019 Nov 15. pii: S2352-3964(19)30733.
Abstract Related articles

DENG LH, Xu FH, Zeng T, Xu XD, et al
[Expression and Clinical Significance of Late Endosomal/Lysosomal Adaptor,Mitogen-activated Protein Kinase and Mammalian Target of Rapamycin Activator 3 in Bladder Carcinoma].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019;41:601-608.
Abstract Related articles

NOFUJI S, Kato R, Sakai Y, Konishi Y, et al
[A Case of paraganglioma of Urinary Bladder].
Hinyokika Kiyo. 2019;65:421-424.
Abstract Related articles

KIMURA H, Uemura Y, Megumi Y, Tachibana M, et al
[A Case Of cT3bN2M0 Pleomorphic Giant Cell Carcinoma of the Bladder without Recurrence after Neoadjuvant Chemotherapy and Radical Cystectomy for 4 Years].
Hinyokika Kiyo. 2019;65:377-380.
Abstract Related articles

LOU Y, Fan L, Hou X, Dominiczak AF, et al
Paroxysmal Hypertension Associated With Urination.
Hypertension. 2019 Sep 30:HYPERTENSIONAHA11913140.
Abstract Related articles

LOUARDI N, Elbahri A, Alami M, Ameur A, et al
[Taeniasis and enterocystoplasty].
Presse Med. 2019;48:987-989.
Abstract Related articles

KIRIGIN M, Lez C, Sarcevic B, Soipi S, et al
PRIMARY MALIGNANT MELANOMA OF THE URINARY BLADDER: CASE REPORT.
Acta Clin Croat. 2019;58:180-182.
Abstract Related articles

ZHOU Q, Yu J, Zheng Q, Wu T, et al
Kinesin family member 3A stimulates cell proliferation, migration, and invasion of bladder cancer cells in vitro and in vivo.
FEBS Open Bio. 2019 Nov 27. doi: 10.1002/2211-5463.12768.
Abstract Related articles

ZHAO X, Li D, Zhao ST, Zhang Y, et al
MiRNA-616 aggravates the progression of bladder cancer by regulating cell proliferation, migration and apoptosis through downregulating SOX7.
Eur Rev Med Pharmacol Sci. 2019;23:9304-9312.
Abstract Related articles

XU S, Yao Q, Liu G, Jin D, et al
Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer.
Eur Radiol. 2019 Nov 26. pii: 10.1007/s00330-019-06484.
Abstract Related articles

YAJIMA K, Akise Y
A Case Report of Graves' Disease Induced by the Anti-Human Programmed Cell Death-1 Monoclonal Antibody Pembrolizumab in a Bladder Cancer Patient.
Case Rep Endocrinol. 2019;2019:2314032.
Abstract Related articles

CHEN L, Liu Y, Zhang Q, Zhang M, et al
p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer.
J Cancer. 2019;10:6207-6216.
Abstract Related articles

YAMASHITA H, Kawasawa YI, Shuman L, Zheng Z, et al
Repression of transcription factor AP-2 alpha by PPARgamma reveals a novel transcriptional circuit in basal-squamous bladder cancer.
Oncogenesis. 2019;8:69.
Abstract Related articles

WEI X, Yang X, Wang B, Yang Y, et al
LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
Cancer Med. 2019 Nov 25. doi: 10.1002/cam4.2684.
Abstract Related articles

WU S, Nitschke K, Heinkele J, Weis CA, et al
ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data.
Cancers (Basel). 2019;11.
Abstract Related articles

CHIANG Y, Wang CC, Tsai YC, Huang CY, et al
Nuclear Factor-kappaB Overexpression is Correlated with Poor Outcomes after Multimodality Bladder-Preserving Therapy in Patients with Muscle-Invasive Bladder Cancer.
J Clin Med. 2019;8.
Abstract Related articles

JIN H, Lin T, Han P, Yao Y, et al
Efficacy of Raman spectroscopy in the diagnosis of bladder cancer: A systematic review and meta-analysis.
Medicine (Baltimore). 2019;98:e18066.
Abstract Related articles

LI Y, Zu X, Hu X, Wang L, et al
Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer.
Med Sci Monit. 2019;25:8928-8939.
Abstract Related articles

ROSIELLO G, Palumbo C, Knipper S, Pecoraro A, et al
Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer.
Urol Oncol. 2019 Nov 21. pii: S1078-1439(19)30442.
Abstract Related articles

SLOAN FA, Yashkin AP, Akushevich I, Inman BA, et al
Longitudinal patterns of cost and utilization of medicare beneficiaries with bladder cancer.
Urol Oncol. 2019 Nov 21. pii: S1078-1439(19)30440.
Abstract Related articles

EROGLU A, Ekin RG, Koc G, Divrik RT, et al
The prognostic value of routine second transurethral resection in patients with newly diagnosed stage pT1 non-muscle-invasive bladder cancer: results from randomized 10-year extension trial.
Int J Clin Oncol. 2019 Nov 23. pii: 10.1007/s10147-019-01581.
Abstract Related articles

ALVAEUS J, Rosenblatt R, Johansson M, Alamdari F, et al
Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy.
World J Urol. 2019 Nov 23. pii: 10.1007/s00345-019-03025.
Abstract Related articles

SHIMIZU T, Yamaguchi K, Yamamoto M, Kurioka R, et al
Identification of HUHS190, a human naftopidil metabolite, as a novel anti-bladder cancer drug.
Bioorg Med Chem Lett. 2019 Nov 8:126744. doi: 10.1016/j.bmcl.2019.126744.
Abstract Related articles

YANG D, Qian H, Fang Z, Xu A, et al
Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR-1184/IGFBP2 axis.
Cancer Med. 2019 Nov 23. doi: 10.1002/cam4.2650.
Abstract Related articles

KONETY BR
Intravesical Therapy for Nonmuscle Invasive Bladder Cancer: Twenty-First Century Edition.
Urol Clin North Am. 2020;47:xiii.
Abstract Related articles

ARENDS TJH, Alfred Witjes J
Apaziquone for Nonmuscle Invasive Bladder Cancer: Where Are We Now?
Urol Clin North Am. 2020;47:73-82.
Abstract Related articles

FABA OR, Pisano F, Krajewski W, Breda A, et al
Salvage Therapies for Non-muscle-invasive Bladder Cancer: Who Will Respond to Bacillus Calmette-Guerin? Predictors and Nomograms.
Urol Clin North Am. 2020;47:5-13.
Abstract Related articles

COOLEY LF, McLaughlin KA, Meeks JJ
Genomic and Therapeutic Landscape of Non-muscle-invasive Bladder Cancer.
Urol Clin North Am. 2020;47:35-46.
Abstract Related articles

KHALED D, Taylor J, Holzbeierlein J
Salvage Therapy for Non-muscle-invasive Bladder Cancer: Novel Intravesical Agents.
Urol Clin North Am. 2020;47:119-128.
Abstract Related articles

CHU CE, Porten SP, Grossfeld GD, Meng MV, et al
Role of Indoleamine-2,3-Dioxygenase Inhibitors in Salvage Therapy for Non-Muscle Invasive Bladder Cancer.
Urol Clin North Am. 2020;47:111-118.
Abstract Related articles

SATHIANATHEN NJ, Regmi S, Gupta S, Konety BR, et al
Immuno-Oncology Approaches to Salvage Treatment for Non-muscle invasive Bladder Cancer.
Urol Clin North Am. 2020;47:103-110.
Abstract Related articles

ABULIZI R, Li B, Zhang CG
Circ_0071662, a novel tumor biomarker, suppresses bladder cancer cell proliferation and invasion by sponging miR-146b-3p.
Oncol Res. 2019 Nov 18. doi: 10.3727/096504019X15740729375088.
Abstract Related articles

SHEN J, Wu JF, Zhang J, Song ZQ, et al
[An animal model of bladder reconstruction by autologous peritoneum transplantation].
Zhonghua Wai Ke Za Zhi. 2019;57:853-859.
Abstract Related articles

KALDYBEKOV DB, Filippov SK, Radulescu A, Khutoryanskiy VV, et al
Maleimide-functionalised PLGA-PEG nanoparticles as mucoadhesive carriers for intravesical drug delivery.
Eur J Pharm Biopharm. 2019;143:24-34.
Abstract Related articles

SAKAMOTO A, Okamoto T, Ikeguchi R, Matsuda S, et al
MRI examination of resected malignant bone tumor can be an option for assessment of the osseous surgical margin.
Br J Radiol. 2019 Aug 6:20190518. doi: 10.1259/bjr.20190518.
Abstract Related articles

SHAN M, Zhang L, Liu Y, Gao C, et al
DNA Methylation Profiles and Their Diagnostic Utility in BC.
Dis Markers. 2019;2019:6328503.
Abstract Related articles

YAMAMICHI G, Nakata W, Tani M, Tsujimura G, et al
High diagnostic efficacy of 5-aminolevulinic acid-induced fluorescent urine cytology for urothelial carcinoma.
Int J Clin Oncol. 2019;24:1075-1080.
Abstract Related articles

ITO K, Kanno T, Sawada A, Saito R, et al
Laparoscopic radical cystectomy in octogenarians: analysis of a Japanese multicenter cohort.
Int J Clin Oncol. 2019;24:1081-1088.
Abstract Related articles

CHEN X, Kost J, Sulovari A, Wong N, et al
A virome-wide clonal integration analysis platform for discovering cancer viral etiology.
Genome Res. 2019;29:819-830.
Abstract Related articles

THE M, Kall L
Integrated Identification and Quantification Error Probabilities for Shotgun Proteomics.
Mol Cell Proteomics. 2019;18:561-570.
Abstract Related articles

GUPTA S, Albertson DJ, Parnell TJ, Butterfield A, et al
Histone Deacetylase Inhibition Has Targeted Clinical Benefit in ARID1A-Mutated Advanced Urothelial Carcinoma.
Mol Cancer Ther. 2019;18:185-195.
Abstract Related articles

SU Y, Du Z, Zhong G, Ya Y, et al
circ5912 suppresses cancer progression via inducing MET in bladder cancer.
Aging (Albany NY). 2019;11.
Abstract Related articles

CHEN M, Nie ZY, Wen XH, Gao YH, et al
m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
Biosci Rep. 2019 Dec 6. pii: 221434. doi: 10.1042/BSR20192892.
Abstract Related articles

IKEDA A, Nosato H, Kochi Y, Kojima T, et al
Support system of cystoscopic diagnosis for bladder cancer based on artificial intelligence.
J Endourol. 2019 Dec 6. doi: 10.1089/end.2019.0509.
Abstract Related articles

CHO CJ, Yang CW, Wu CL, Ho JY, et al
The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol.
Oncol Lett. 2019;18:6869-6876.
Abstract Related articles

TAN S, Bian X, Wu B, Chen X, et al
RASSF6 Is Downregulated In Human Bladder Cancers And Regulates Doxorubicin Sensitivity And Mitochondrial Membrane Potential Via The Hippo Signaling Pathway.
Onco Targets Ther. 2019;12:9189-9200.
Abstract Related articles

WANG J, Tan X, Guo Q, Lin X, et al
FGF9 inhibition by a novel binding peptide has efficacy in gastric and bladder cancer per se and reverses resistance to cisplatin.
Pharmacol Res. 2019 Dec 2:104575. doi: 10.1016/j.phrs.2019.104575.
Abstract Related articles

SANGUEDOLCE F, Cormio L, Carrieri G, Calo B, et al
Role of androgen receptor expression in non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
Histol Histopathol. 2019 Dec 5:18189. doi: 10.14670.
Abstract Related articles

SATYAL U, Srivastava A, Abbosh PH
Urine Biopsy-Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer.
Front Oncol. 2019;9:1266.
Abstract Related articles

CASADEI C, Dizman N, Schepisi G, Cursano MC, et al
Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors.
Ther Adv Med Oncol. 2019;11:1758835919890285.
Abstract Related articles

LI Y, Chen R, Li Z, Cheng H, et al
miR-204 Negatively Regulates Cell Growth And Metastasis By Targeting ROBO4 In Human Bladder Cancer.
Onco Targets Ther. 2019;12:8515-8524.
Abstract Related articles

GUO Y, Yuan X, Li K, Dai M, et al
GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
Cell Death Differ. 2019 Dec 4. pii: 10.1038/s41418-019-0466.
Abstract Related articles

WU S, Liu Y, Michalek JE, Mesa RA, et al
Carotenoid Intake and Circulating Carotenoids Are Inversely Associated with the Risk of Bladder Cancer: A Dose-Response Meta-analysis.
Adv Nutr. 2019 Dec 4. pii: 5652213. doi: 10.1093.
Abstract Related articles

YU X, Wang ZL, Han CL, Wang MW, et al
LncRNA CASC15 functions as an oncogene by sponging miR-130b-3p in bladder cancer.
Eur Rev Med Pharmacol Sci. 2019;23:9814-9820.
Abstract Related articles

LIM JH, Sundar S
Prognosis of early stage small cell bladder cancer is not always dismal.
ESMO Open. 2019;4:e000559.
Abstract Related articles

BA M, Cui S, Long H, Gong Y, et al
Development of a high-precision bladder hyperthermic intracavitary chemotherapy device for bladder cancer and pharmacokinetic study.
BMC Urol. 2019;19:126.
Abstract Related articles

LOPEZ-BELTRAN A, Cheng L, Gevaert T, Blanca A, et al
Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers.
Expert Rev Mol Diagn. 2019 Dec 4. doi: 10.1080/14737159.2020.1699791.
Abstract Related articles

ZHANG C, Shen K, Zheng Y, Qi F, et al
Genome-wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer.
Cancer Med. 2019 Dec 3. doi: 10.1002/cam4.2665.
Abstract Related articles

WISSING MD, Kassouf W, Tanguay S, Aprikian AG, et al
The use of perioperative chemotherapy in patients undergoing radical cystectomy for bladder cancer in Quebec (Canada), 2000-2016.
Can Urol Assoc J. 2019 Nov 29. pii: cuaj.6094. doi: 10.5489/cuaj.6094.
Abstract Related articles

PENG W, Dong N, Wu S, Gui D, et al
miR-4500 suppresses cell proliferation and migration in bladder cancer via inhibition of STAT3/CCR7 pathway.
J Cell Biochem. 2019 Dec 1. doi: 10.1002/jcb.29558.
Abstract Related articles

GUO J, Chen Z, Jiang H, Yu Z, et al
The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/beta-catenin signaling pathway.
Cancer Cell Int. 2019;19:312.
Abstract Related articles

LI X, Shu K, Zhou J, Yu Q, et al
Preoperative Plasma Fibrinogen and D-dimer as Prognostic Biomarkers for Non-Muscle-Invasive Bladder Cancer.
Clin Genitourin Cancer. 2019 Nov 6. pii: S1558-7673(19)30329.
Abstract Related articles

RADKIEWICZ C, Edgren G, Johansson ALV, Jahnson S, et al
Sex Differences in Urothelial Bladder Cancer Survival.
Clin Genitourin Cancer. 2019 Nov 6. pii: S1558-7673(19)30324.
Abstract Related articles

D'ANDREA D, Soria F, Abufaraj M, Pones M, et al
Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer.
Clin Genitourin Cancer. 2019 Nov 6. pii: S1558-7673(19)30325.
Abstract Related articles

LIU Y, Wu G
NNT-AS1 enhances bladder cancer cell growth by targeting miR-1301-3p/PODXL axis and activating Wnt pathway.
Neurourol Urodyn. 2019 Nov 29. doi: 10.1002/nau.24238.
Abstract Related articles

PACKIAM VT, Werntz RP, Steinberg GD
Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG Shortage.
Curr Urol Rep. 2019;20:84.
Abstract Related articles

ARON M
Variant Histology in Bladder Cancer-Current Understanding of Pathologic Subtypes.
Curr Urol Rep. 2019;20:80.
Abstract Related articles

GURRAM S, Muthigi A, Egan J, Stamatakis L, et al
Imaging in Localized Bladder Cancer: Can Current Diagnostic Modalities Provide Accurate Local Tumor Staging?
Curr Urol Rep. 2019;20:82.
Abstract Related articles

BOSSHARD P, Roth B
[Cisplatin-based chemotherapy in muscle-invasive bladder cancer: soon outdated ?]
Rev Med Suisse. 2019;15:2190-2194.
Abstract Related articles

ZHANG N, Chen S, Wu L, Wu Y, et al
Identification of Cancer-Specific Methylation of Gene Combination for the Diagnosis of Bladder Cancer.
J Cancer. 2019;10:6761-6766.
Abstract Related articles

SONG Z, Zhang Q, Zhu J, Yin G, et al
Identification of urinary hsa_circ _0137439 as potential biomarker and tumor regulator of bladder cancer.
Neoplasma. 2019 Nov 18. pii: 181214N970. doi: 10.4149/neo_2018_181214.
Abstract Related articles

NARAYAN VM, Dinney CPN
Intravesical Gene Therapy.
Urol Clin North Am. 2020;47:93-101.
Abstract Related articles

BROOKS NA, O'Donnell MA
Combination Intravesical Therapy.
Urol Clin North Am. 2020;47:83-91.
Abstract Related articles

TAN WP, Longo TA, Inman BA
Heated Intravesical Chemotherapy: Biology and Clinical Utility.
Urol Clin North Am. 2020;47:55-72.
Abstract Related articles

HAAS CR, McKiernan JM
Salvage Therapy Using Bacillus Calmette-Guerin Derivatives or Single Agent Chemotherapy.
Urol Clin North Am. 2020;47:47-54.
Abstract Related articles

LI R, Kamat AM
Predictors of Response to Intravesical Therapy.
Urol Clin North Am. 2020;47:23-33.
Abstract Related articles

BECKER REN, Kates MR, Bivalacqua TJ
Identification of Candidates for Salvage Therapy: The Past, Present, and Future of Defining Bacillus Calmette-Guerin Failure.
Urol Clin North Am. 2020;47:15-21.
Abstract Related articles

KONETY BR, Narayan VM, Dinney CPN
Bacillus Calmette-Guerin Salvage Therapy: Definitions and Context.
Urol Clin North Am. 2020;47:1-4.
Abstract Related articles

SOUKUP V, Capoun O, Pesl M, Vavrova L, et al
The significance of calprotectin, CD147, APOA4 and DJ-1 in non-invasive detection of urinary bladder carcinoma.
Neoplasma. 2019;66:1019-1023.
Abstract Related articles

GIANNARINI G, Crestani A, Inferrera A, Rossanese M, et al
Impact of enhanced recovery after surgery protocols versus standard of care on perioperative outcomes of radical cystectomy: a systematic review and meta-analysis of comparative studies.
Minerva Urol Nefrol. 2019;71:309-323.
Abstract Related articles

HURLE R, Lazzeri M, Saita A, Naselli A, et al
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: pure versus non-pure CIS.
Minerva Urol Nefrol. 2019;71:406-412.
Abstract Related articles

HSU YH, Huang HP, Chang HR
The uremic toxin p-cresol promotes the invasion and migration on carcinoma cells via Ras and mTOR signaling.
Toxicol In Vitro. 2019;58:126-131.
Abstract Related articles

ATAKA R, Sato S, Matsubara K, Takagi M, et al
Small bowel obstruction due to internal hernia caused by the ureter after laparoscopic radical cystectomy and ileal conduit: A case report.
Asian J Endosc Surg. 2019;12:189-191.
Abstract Related articles

SHAFIEIAN Z, Bahari G, Hashemi M, Nakhaee A, et al
SIRT1 Gene Polymorphisms Are Associated with Urinary Bladder Cancer in an Iranian Population.
Rep Biochem Mol Biol. 2019;8:194-199.
Abstract Related articles

RUAN H, Li Y, Wang X, Sun B, et al
CRYAB inhibits migration and invasion of bladder cancer cells through the PI3K/AKT and ERK pathways.
Jpn J Clin Oncol. 2019 Dec 12. pii: 5673759. doi: 10.1093.
Abstract Related articles

CHEN Q, Hu J, Deng J, Fu B, et al
Bioinformatics Analysis Identified Key Molecular Changes in Bladder Cancer Development and Recurrence.
Biomed Res Int. 2019;2019:3917982.
Abstract Related articles

VANTAKU V, Donepudi SR, Ambati CR, Jin F, et al
Correction: Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer.
Oncotarget. 2019;10:6843-6844.
Abstract Related articles

WANG J, Zhang H, Situ J, Li M, et al
KCNQ1OT1 aggravates cell proliferation and migration in bladder cancer through modulating miR-145-5p/PCBP2 axis.
Cancer Cell Int. 2019;19:325.
Abstract Related articles

ZAITSU M, Lee HE, Lee S, Takeuchi T, et al
Occupational disparities in bladder cancer survival: A population-based cancer registry study in Japan.
Cancer Med. 2019 Dec 11. doi: 10.1002/cam4.2768.
Abstract Related articles

JOSEPH M, Enting D
Immune Responses in Bladder Cancer-Role of Immune Cell Populations, Prognostic Factors and Therapeutic Implications.
Front Oncol. 2019;9:1270.
Abstract Related articles

LUO Y, Zeng G, Wu S
Identification of Microenvironment-Related Prognostic Genes in Bladder Cancer Based on Gene Expression Profile.
Front Genet. 2019;10:1187.
Abstract Related articles

SONPAVDE G, Necchi A, Gupta S, Steinberg GD, et al
ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer.
Future Oncol. 2019 Dec 11. doi: 10.2217/fon-2019-0611.
Abstract Related articles

ZIRAKZADEH AA, Sherif A, Rosenblatt R, Ahlen Bergman E, et al
Tumour-associated B cells in urothelial urinary bladder cancer.
Scand J Immunol. 2019 Dec 10:e12830. doi: 10.1111/sji.12830.
Abstract Related articles

CHEN S, Zhou Q, Guo Z, Wang Y, et al
Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway.
J Cell Mol Med. 2019 Dec 10. doi: 10.1111/jcmm.14878.
Abstract Related articles

HE Q, Huang L, Yan D, Bi J, et al
CircPTPRA acts as a tumor suppressor in bladder cancer by sponging miR-636 and upregulating KLF9.
Aging (Albany NY). 2019;11.
Abstract Related articles

SU Y, Feng W, Zhong G, Ya Y, et al
ciRs-6 upregulates March1 to suppress bladder cancer growth by sponging miR-653.
Aging (Albany NY). 2019;11.
Abstract Related articles

MOHAMMED A, Miller MS, Lubet RA, Suen CS, et al
Combination of erlotinib and naproxen employing pulsatile or intermittent dosing profoundly inhibits urinary bladder cancers.
Cancer Prev Res (Phila). 2019 Dec 9. pii: 1940-6207.CAPR-19-0339.
Abstract Related articles

YOON HY, Yang HM, Kim CH, Goo YT, et al
Enhanced Intracellular Delivery of BCG Cell Wall Skeleton into Bladder Cancer Cells Using Liposomes Functionalized with Folic Acid and Pep-1 Peptide.
Pharmaceutics. 2019;11.
Abstract Related articles

POLIKARPOV D, Liang L, Care A, Sunna A, et al
Functionalized Upconversion Nanoparticles for Targeted Labelling of Bladder Cancer Cells.
Biomolecules. 2019;9.
Abstract Related articles

YAO Z, Zheng Z, Ke W, Wang R, et al
Prognostic nomogram for bladder cancer with brain metastases: a National Cancer Database analysis.
J Transl Med. 2019;17:411.
Abstract Related articles

LI F, Su M, Zhao H, Xie W, et al
HnRNP-F promotes cell proliferation by regulating TPX2 in bladder cancer.
Am J Transl Res. 2019;11:7035-7048.
Abstract Related articles

WEI Y, Zhang Y, Meng Q, Cui L, et al
Hypoxia-induced circular RNA has_circRNA_403658 promotes bladder cancer cell growth through activation of LDHA.
Am J Transl Res. 2019;11:6838-6849.
Abstract Related articles

GRIVAS P, Bismar TA, Alva AS, Huang HC, et al
Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy.
Urol Oncol. 2019 Dec 4. pii: S1078-1439(19)30459.
Abstract Related articles

YI S, Park H
A rare case of aquaporin-4-antibody-positive neuromyelitis optica associated with bladder cancer.
Mult Scler Relat Disord. 2019;38:101499.
Abstract Related articles

BULKLEY JE, O'Keeffe-Rosetti M, Wendel CS, Davis JV, et al
The effect of multiple recruitment contacts on response rates and patterns of missing data in a survey of bladder cancer survivors 6 months after cystectomy.
Qual Life Res. 2019 Dec 6. pii: 10.1007/s11136-019-02379.
Abstract Related articles

CRISPEN PL, Kusmartsev S
Mechanisms of immune evasion in bladder cancer.
Cancer Immunol Immunother. 2019 Dec 6. pii: 10.1007/s00262-019-02443.
Abstract Related articles

XU J, Hua X, Yang R, Jin H, et al
XIAP Interaction with E2F1 and Sp1 via its BIR2 and BIR3 domains specific activated MMP2 to promote bladder cancer invasion.
Oncogenesis. 2019;8:71.
Abstract Related articles

MONTAZERI K, Bellmunt J
Erdafitinib for the treatment of metastatic bladder cancer.
Expert Rev Clin Pharmacol. 2019 Dec 6. doi: 10.1080/17512433.2020.1702025.
Abstract Related articles

MANI J, Fleger J, Rutz J, Maxeiner S, et al
Curcumin combined with exposure to visible light blocks bladder cancer cell adhesion and migration by an integrin dependent mechanism.
Eur Rev Med Pharmacol Sci. 2019;23:10564-10574.
Abstract Related articles

VARTOLOMEI L, Vartolomei MD, Shariat SF
Bladder Cancer: Depression, Anxiety, and Suicidality Among the Highest-risk Oncology Patients.
Eur Urol Focus. 2019 Dec 10. pii: S2405-4569(19)30330.
Abstract Related articles

LV S, Yu J, Zhao Y, Li H, et al
A Microfluidic Detection System for Bladder Cancer Tumor Cells.
Micromachines (Basel). 2019;10.
Abstract Related articles

LIU J, Li S, Cheng X, DU P, et al
HOXB2 is a Putative Tumour Promotor in Human Bladder Cancer.
Anticancer Res. 2019;39:6915-6921.
Abstract Related articles

DHARIWAL R, Pindoria N, Dasgupta P, Khan MS, et al
#Checkmate: could checkpoint inhibitors be the game changer in the fight against metastatic urothelial carcinoma?
BJU Int. 2019;123:203-207.
Abstract Related articles

NURMINEN P, Ettala O, Seppanen M, Taimen P, et al
Urine cytology is a feasible tool for assessing erythematous bladder lesions after bacille Calmette-Guerin (BCG) treatment.
BJU Int. 2019;123:246-251.
Abstract Related articles

KINNEAR N, O'Callaghan M, Hennessey D, Liddell H, et al
Intra-operative cell salvage in urological surgery: a systematic review and meta-analysis of comparative studies.
BJU Int. 2019;123:210-219.
Abstract Related articles

TAYLOR J, Becher E, Steinberg GD
Update on the Guideline of Guidelines: Non-Muscle Invasive Bladder Cancer.
BJU Int. 2019 Oct 9. doi: 10.1111/bju.14915.
Abstract Related articles

KHETRAPAL P, Kelly JD, Catto JWF, Vasdev N, et al
Does the robot have a role in radical cystectomy?
BJU Int. 2019;123:380-382.
Abstract Related articles

KITA Y, Hamada A, Saito R, Teramoto Y, et al
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies.
Br J Cancer. 2019 Nov 1. pii: 10.1038/s41416-019-0609.
Abstract Related articles

FLETCHER SA, Cole AP, Lu C, Marchese M, et al
The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years.
Cancer. 2019 Oct 18. doi: 10.1002/cncr.32562.
Abstract Related articles

CUI H, Tang M, Zhang M, Liu S, et al
Variants in the PSCA gene associated with risk of cancer and nonneoplastic diseases: systematic research synopsis, meta-analysis and epidemiological evidence.
Carcinogenesis. 2019;40:70-83.
Abstract Related articles

SOTTNIK JL, Mallaredy V, Chauca-Diaz A, Ritterson Lew C, et al
Elucidating the role of Agl in bladder carcinogenesis by generation and characterization of genetically engineered mice.
Carcinogenesis. 2019;40:194-201.
Abstract Related articles

GRIVAS P
DNA Damage Response Gene Alterations in Urothelial Cancer: Ready for Practice?
Clin Cancer Res. 2019;25:907-909.
Abstract Related articles

KATES M, Matoso A, Choi W, Baras AS, et al
Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG Unresponsive Trials.
Clin Cancer Res. 2019 Nov 11. pii: 1078-0432.CCR-19-1920.
Abstract Related articles

MORI K, D'Andrea D, Enikeev DV, Egawa S, et al
En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature.
Curr Opin Urol. 2019 Nov 12. doi: 10.1097/MOU.0000000000000697.
Abstract Related articles

KETTUNEN K, Bostrom P, Taimen P
Reply to Xuefeng Liu's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol. In press. https://do
Eur Urol. 2019 Sep 26. pii: S0302-2838(19)30731.
Abstract Related articles

LIU X
Re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.06.016: Can Patie
Eur Urol. 2019 Sep 26. pii: S0302-2838(19)30734.
Abstract Related articles

KAMOUN A, Reynies A, Allory Y, Sjodahl G, et al
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.
Eur Urol. 2019 Sep 25. pii: S0302-2838(19)30695.
Abstract Related articles

LEOW JJ, Catto JWF, Efstathiou JA, Gore JL, et al
Quality Indicators for Bladder Cancer Services: A Collaborative Review.
Eur Urol. 2019 Sep 25. pii: S0302-2838(19)30690.
Abstract Related articles

KRIEGMAIR MC, Rother J, Grychtol B, Theuring M, et al
Multiparametric Cystoscopy for Detection of Bladder Cancer Using Real-time Multispectral Imaging.
Eur Urol. 2019 Sep 26. pii: S0302-2838(19)30674.
Abstract Related articles

YATAI KB, Tran H, Dunning MJ, Wang D, et al
Sources of Bias Within Consensus Subtypes of Muscle-invasive Bladder Cancer.
Eur Urol. 2019 Oct 23. pii: S0302-2838(19)30760.
Abstract Related articles

DEL GIUDICE F, Barchetti G, De Berardinis E, Pecoraro M, et al
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
Eur Urol. 2019 Nov 4. pii: S0302-2838(19)30757.
Abstract Related articles

WITJES JA, Babjuk M, Bellmunt J, Bruins HM, et al
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort(dagger): Under the Auspices of the EAU-ESMO Guidelines Committees.
Eur Urol. 2019 Nov 16. pii: S0302-2838(19)30763.
Abstract Related articles

WILLIAMS SB, Black PC, Dyrskjot L, Seiler R, et al
Re: Aurelie Kamoun, Aurelien de Reynies, Yves Allory, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.09.006: A Statement from the International Bladder Cancer Ne
Eur Urol. 2019 Nov 28. pii: S0302-2838(19)30874.
Abstract Related articles

THIBAULT C, Lavaud P, Loriot Y
Studying Rarity in Bladder Cancer.
Eur Urol. 2019 Dec 4. pii: S0302-2838(19)30891.
Abstract Related articles

ZENG H, Liu Z, Wang Z, Zhou Q, et al
Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses.
Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32715.
Abstract Related articles

JACK S, Madhivanan K, Ramadesikan S, Subramanian S, et al
A Novel, Safe, Fast, Efficient Treatment for Her2-positive and Negative Bladder Cancer Utilizing an EGF-Anthrax Toxin Chimera.
Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32719.
Abstract Related articles

XU M, Gu M, Zhou J, Da J, et al
Interaction of YAP1 and mTOR promotes bladder cancer progression.
Int J Oncol. 2019 Nov 25. doi: 10.3892/ijo.2019.4922.
Abstract Related articles

LIN F, Yin HB, Li XY, Zhu GM, et al
Bladder cancer cellsecreted exosomal miR21 activates the PI3K/AKT pathway in macrophages to promote cancer progression.
Int J Oncol. 2019 Dec 3. doi: 10.3892/ijo.2019.4933.
Abstract Related articles

MATSUMOTO H
Editorial Comment from Dr Matsumoto to Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.
Int J Urol. 2019 Oct 6. doi: 10.1111/iju.14131.
Abstract Related articles

FUKUHARA H
Editorial Comment from Dr Fukuhara to Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.
Int J Urol. 2019 Oct 11. doi: 10.1111/iju.14124.
Abstract Related articles

KIKUCHI E, Hayakawa N, Fukumoto K, Shigeta K, et al
Bacillus Calmette-Guerin-unresponsive non-muscle-invasive bladder cancer: Its definition and future therapeutic strategies.
Int J Urol. 2019 Dec 3. doi: 10.1111/iju.14153.
Abstract Related articles

GORGEL SN, Akin Y, Koc EM, Kose O, et al
Retrospective study of systemic immune-inflammation index in muscle invasive bladder cancer: initial results of single centre.
Int Urol Nephrol. 2019 Oct 28. pii: 10.1007/s11255-019-02325.
Abstract Related articles

GULLU AMURAN G, Tinay I, Filinte D, Ilgin C, et al
Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.
Int Urol Nephrol. 2019 Nov 2. pii: 10.1007/s11255-019-02328.
Abstract Related articles

OTTOSSON K, Pelander S, Johansson M, Huge Y, et al
The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access: a multicenter evaluation.
Int Urol Nephrol. 2019 Nov 19. pii: 10.1007/s11255-019-02338.
Abstract Related articles

YAMASHITA R, Nakamura M, Notsu A, Hashizume A, et al
The occurrence of high-grade complications after radical cystectomy worsens oncological outcomes in patients with bladder cancer.
Int Urol Nephrol. 2019 Nov 22. pii: 10.1007/s11255-019-02341.
Abstract Related articles

LIEM EI, Oddens JR, Vernooij R, Li R, et al
The Role of Fluorescence in Situ Hybridization for Predicting Recurrence after Adjuvant Bacillus Calmette-Guerin in Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer Patients: A Systematic Review and Meta-Analysis of Individual Patient Da
J Urol. 2019 Sep 24:101097JU0000000000000566. doi: 10.1097/JU.0000000000000566.
Abstract Related articles

CHANG SS
Re: Occupation and Bladder Cancer Phenotype: Identification of Workplace Patterns That Increase the Risk of Advanced Disease beyond Overall Incidence.
J Urol. 2019 Oct 16:101097JU0000000000000599. doi: 10.1097/JU.0000000000000599.
Abstract Related articles

RITCH CR, Velasquez MC, Kwon D, Becerra MF, et al
Utility and Validation of the AUA/SUO Risk Grouping for Non-muscle Invasive Bladder Cancer in a Contemporary Cohort.
J Urol. 2019 Oct 14:101097JU0000000000000593. doi: 10.1097/JU.0000000000000593.
Abstract Related articles

MONTORSI F, Moschini M, Briganti A
Re: Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guerin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial.
J Urol. 2019 Oct 24:101097JU0000000000000624. doi: 10.1097/JU.0000000000000624.
Abstract Related articles

LOTAN Y
Re: Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guerin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial.
J Urol. 2019 Oct 25:101097JU0000000000000625. doi: 10.1097/JU.0000000000000625.
Abstract Related articles

WEIN AJ
Re: Long-Term Follow-Up after Cystectomy for Bladder Pain Syndrome: Pain Status, Sexual Function and Quality of Life.
J Urol. 2019;202:1101-1102.
Abstract Related articles

LENIS AT
Editorial Comment.
J Urol. 2019;202:1134-1135.
Abstract Related articles

ALBERSHEIM J, Sathianathen NJ, Zabell J, Renier J, et al
Skeletal Muscle and Fat Mass Indexes Predict Discharge Disposition after Radical Cystectomy.
J Urol. 2019;202:1143-1149.
Abstract Related articles

SIGHINOLFI MC, Rocco B, Micali S, Bianchi G, et al
Re: Accurate Quantification of Residual Cancer Cells in Pelvic Washing Reveals Association with Cancer Recurrence following Robot-Assisted Radical Cystectomy.
J Urol. 2019;202:1271-1272.
Abstract Related articles

RASKOLNIKOV D, Brown B, Holt SK, Ball AL, et al
Reduction of Pain during Flexible Cystoscopy: A Systematic Review and Meta-Analysis.
J Urol. 2019;202:1136-1142.
Abstract Related articles

LABBATE C, Werntz RP, Adamic B, Steinberg GD, et al
The Impact of Omission of Intraoperative Frozen Section Prior to Orthotopic Neobladder Reconstruction.
J Urol. 2019;202:763-769.
Abstract Related articles

AL HUSSEIN AL AWAMLH B, Shoag JE, Ravikumar V, Posada L, et al
Association of Smoking and Death from Genitourinary Malignancies: Analysis of the National Longitudinal Mortality Study.
J Urol. 2019;202:1248-1254.
Abstract Related articles

CHANG SS
Re: Radiofrequency-Induced Thermo-Chemotherapy Effect versus a Second Course of Bacillus Calmette-Guerin or Institutional Standard in Patients with Recurrence of Non-Muscle-Invasive Bladder Cancer following Induction or Maintenance Bacillus Calmette-G
J Urol. 2019 Dec 3:101097JU0000000000000676. doi: 10.1097/JU.0000000000000676.
Abstract Related articles

SINGLA N
Editorial Comment.
J Urol. 2019;202:688.
Abstract Related articles

SCHAEFFER EM
Re: Reduced Recurrence of Low-Grade Papillary Bladder Tumors Associated with Asymptomatic Bacteriuria.
J Urol. 2019;202:849.
Abstract Related articles

ATALA A
Re: Recurrent Activating Mutations of PPARgamma Associated with Luminal Bladder Tumors.
J Urol. 2019;202:869.
Abstract Related articles

SEFIK E, Bozkurt IH, Basmaci I, Celik S, et al
Re: Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial.
J Urol. 2019;202:819.
Abstract Related articles

LUO Y, Wang X, Xiao Y
Re: Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial.
J Urol. 2019;202:819-820.
Abstract Related articles

STEINBERG RL, Thomas LJ, Brooks N, Mott SL, et al
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy of Non-muscle Invasive Bladder Cancer.
J Urol. 2019 Dec 10:101097JU0000000000000688. doi: 10.1097/JU.0000000000000688.
Abstract Related articles

OSEI-AMPONSA V, Buckwalter JM, Shuman L, Zheng Z, et al
Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer.
Oncogene. 2019 Oct 21. pii: 10.1038/s41388-019-1063.
Abstract Related articles

LIU F, Zhang H, Xie F, Tao D, et al
Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p/MMP9 axis.
Oncogene. 2019 Nov 8. pii: 10.1038/s41388-019-1092.
Abstract Related articles

YANG R, Xu J, Hua X, Tian Z, et al
Overexpressed miR-200a promotes bladder cancer invasion through direct regulating Dicer/miR-16/JNK2/MMP-2 axis.
Oncogene. 2019 Nov 26. pii: 10.1038/s41388-019-1120.
Abstract Related articles

NEUZILLET Y, Geiss R, Paillaud E, Mongiat-Artus P, et al
[Optimizing the management of bladder cancer in older patients].
Prog Urol. 2019;29:849-864.
Abstract Related articles

MARQUETTE T, Walz J, Rybikowski S, Maubon T, et al
[Safety of Hyperthermic IntraVEsical Chemotherapy (HIVEC) for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients].
Prog Urol. 2019 Nov 28. pii: S1166-7087(19)30609.
Abstract Related articles

FRAISSE G, Renard Y, Lebacle C, Masson-Lecomte A, et al
[Is sarcopenia a morbi-mortality factor in the treatment of localized muscle-invasive bladder cancer?]
Prog Urol. 2019 Dec 6. pii: S1166-7087(19)30610.
Abstract Related articles

JEGLINSCHI S, Schirmann A, Durand M, Sanchez S, et al
Factors affecting guideline adherence in the initial treatment of non-muscle invasive bladder cancer: Retrospective study in a French peripheral hospital.
Prog Urol. 2019 Dec 5. pii: S1166-7087(19)30611.
Abstract Related articles

HAUTMANN RE, Bolenz C, Volkmer B
Unexpected Early Oncologic Mortality after Open Radical Cystectomy for Bladder Cancer: Who Is to Be Blamed?
Urol Int. 2019 Sep 27:1-6. doi: 10.1159/000503398.
Abstract Related articles

FROEHNER M, Muallah D, Koch R, Hubler M, et al
Socioeconomic Status-Related Parameters as Predictors of Competing (Non-Bladder Cancer) Mortality after Radical Cystectomy.
Urol Int. 2019 Oct 22:1-8. doi: 10.1159/000502781.
Abstract Related articles

ZIEGELMUELLER BK, Jokisch JF, Buchner A, Grimm T, et al
Long-Term Follow-Up and Oncological Outcome of Patients Undergoing Radical Cystectomy for Bladder Cancer following an Enhanced Recovery after Surgery (ERAS) Protocol: Results of a Large Randomized, Prospective, Single-Center Study.
Urol Int. 2019 Dec 4:1-7. doi: 10.1159/000504236.
Abstract Related articles

ALBARAKATI N, Khayyat D, Dallol A, Al-Maghrabi J, et al
The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer.
BMC Cancer. 2019;19:991.
Abstract Related articles

ZHANG J, Wang Y, Weng H, Wang D, et al
Management of non-muscle-invasive bladder cancer: quality of clinical practice guidelines and variations in recommendations.
BMC Cancer. 2019;19:1054.
Abstract Related articles

MOLENAAR RJ, van Hattum JW, Brummelhuis IS, Oddens JR, et al
Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer.
BMC Cancer. 2019;19:1133.
Abstract Related articles

ZENG S, Liu A, Dai L, Yu X, et al
Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms.
BMC Cancer. 2019;19:604.
Abstract Related articles

WANG Z, Liu X, Liu X, Sun H, et al
UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.
BMC Cancer. 2019;19:1195.
Abstract Related articles

BOURN J, Rathore K, Donnell R, White W, et al
Detection of carcinogen-induced bladder cancer by fluorocoxib A.
BMC Cancer. 2019;19:1152.
Abstract Related articles

FANG CW, Hsieh VC, Huang SK, Tsai IJ, et al
A population-based cohort study examining the association of documented bladder diverticulum and bladder cancer risk in urology patients.
PLoS One. 2019;14:e0222875.
Abstract Related articles

KIM MJ, Chi BH, Yoo JJ, Ju YM, et al
Structure establishment of three-dimensional (3D) cell culture printing model for bladder cancer.
PLoS One. 2019;14:e0223689.
Abstract Related articles

GRIFFITHS GO, Cowan RA, Grigor KM, Uscinska BM, et al
BA08: An open-label, single-arm, non-randomised, phase 2 trial of cisplatin, methotrexate and vinblastine (CMV) for pure squamous cell cancer of the urinary tract.
PLoS One. 2019;14:e0210785.
Abstract Related articles

GOFRIT ON, Klein BY, Cohen IR, Ben-Hur T, et al
Bacillus Calmette-Guerin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients.
PLoS One. 2019;14:e0224433.
Abstract Related articles

HE S, Carman CV, Lee JH, Lan B, et al
The tumor suppressor p53 can promote collective cellular migration.
PLoS One. 2019;14:e0202065.
Abstract Related articles

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:

;